Literature DB >> 20691730

Nonspecific CXCR7 antibodies.

Robert D Berahovich, Mark E T Penfold, Thomas J Schall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20691730     DOI： 10.1016/j.imlet.2010.06.010

Source DB:  PubMed          Journal:  Immunol Lett        ISSN： 0165-2478            Impact factor:   3.685


× No keyword cloud information.
  16 in total

1.  Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.

Authors:  Babak Behnam Azad; Ala Lisok; Samit Chatterjee; John T Poirier; Mrudula Pullambhatla; Gary D Luker; Martin G Pomper; Sridhar Nimmagadda
Journal:  J Nucl Med       Date:  2016-02-23       Impact factor: 10.057

2.  Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.

Authors:  Franck Talmont; Lionel Moulédous
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-01-24       Impact factor: 3.000

3.  Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels.

Authors:  Robert D Berahovich; Brian A Zabel; Susanna Lewén; Matthew J Walters; Karen Ebsworth; Yu Wang; Juan C Jaen; Thomas J Schall
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

4.  The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth.

Authors:  Rajendra Kumar Singh; Bal L Lokeshwar
Journal:  Cancer Res       Date:  2011-03-11       Impact factor: 12.701

5.  Induction of C-X-C chemokine receptor type 7 (CXCR7) switches stromal cell-derived factor-1 (SDF-1) signaling and phagocytic activity in macrophages linked to atherosclerosis.

Authors:  Wanshu Ma; Yiwei Liu; Nicholas Ellison; Jianzhong Shen
Journal:  J Biol Chem       Date:  2013-04-18       Impact factor: 5.157

6.  Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.

Authors:  Harold H Bach; Yee M Wong; Abhishek Tripathi; Amanda M Nevins; Richard L Gamelli; Brian F Volkman; Kenneth L Byron; Matthias Majetschak
Journal:  Mol Med       Date:  2014-10-13       Impact factor: 6.354

Review 7.  Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.

Authors:  Anup Kumar Singh; Rakesh Kumar Arya; Arun Kumar Trivedi; Sabyasachi Sanyal; Rathindranath Baral; Olivier Dormond; David M Briscoe; Dipak Datta
Journal:  Cytokine Growth Factor Rev       Date:  2012-09-16       Impact factor: 7.638

8.  Commercially available antibodies directed against α-adrenergic receptor subtypes and other G protein-coupled receptors with acceptable selectivity in flow cytometry experiments.

Authors:  Abhishek Tripathi; Vadim Gaponenko; Matthias Majetschak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-14       Impact factor: 3.000

9.  CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver.

Authors:  E Guillemot; B Karimdjee-Soilihi; E Pradelli; M Benchetrit; E Goguet-Surmenian; M-A Millet; F Larbret; J-F Michiels; D Birnbaum; P Alemanno; H Schmid-Antomarchi; A Schmid-Alliana
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

10.  CXCR7 protein expression in human adult brain and differentiated neurons.

Authors:  Saori Shimizu; Michael Brown; Rajarshi Sengupta; Mark E Penfold; Olimpia Meucci
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.